Pharmaceutical Contracts with Accession Option
Contracts are sought for pharmaceuticals containing specific active ingredients or combinations thereof. This tender is aimed at suppliers who can provide these medications.
CONTRACTING AUTHORITY
Name
BARMER Beschaffung und Vergabe
City
Wuppertal
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (41)
Aclidinium-Kation Arzneimittel
Betahistin Arzneimittel
Betamethason dipropionat + Salicylsäure Arzneimittel
Ceftazidim Arzneimittel
Ciclopirox Arzneimittel (Rx)
Clobetasol 17-propionat Arzneimittel (LOE, exkl. N3)
Clostridium botulinum Toxin Typ A Arzneimittel (exkl. Lifestyle-AM)
Clostridium botulinum Toxin Typ A Arzneimittel (Onabotulinum, exkl. Lifestyle-AM)
Colesevelam hydrochlorid Arzneimittel
Darifenacin Arzneimittel
Dexketoprofen Arzneimittel (parenteral)
Doravirin Arzneimittel
Elbasvir + Grazoprevir Arzneimittel
Epinephrin Arzneimittel (ATC C01CA24, exkl. OTC + nasale Anwendung)
Formoterol Arzneimittel (DOS)
Hepatitis-B-Immunglobulin vom Menschen Arzneimittel (Hepatect®)
Imatinib Arzneimittel (200 mg)
Infliximab Arzneimittel (i.v.)
Infliximab Arzneimittel (s.c.)
Mebendazol Arzneimittel (500 mg)
Methocarbamol Arzneimittel (parenteral)
Methylprednisolon aceponat Arzneimittel (EMU)
Norfloxacin Arzneimittel
Nystatin Arzneimittel (OTC, exkl. ATC G01AA01)
Oxybutynin Arzneimittel (PFT)
Pantoprazol + Amoxicillin + Clarithromycin Arzneimittel
Peginterferon alfa-2a Arzneimittel
Perampanel Arzneimittel
Piperacillin + Tazobactam Arzneimittel
Propranolol Arzneimittel (LSE_REK)
Risedronsäure Arzneimittel (exkl. 32,48 mg)
Risperidon Arzneimittel (parenteral)
Sofosbuvir + Velpatasvir + Voxilaprevir Arzneimittel
Sumatriptan Arzneimittel (nasal)
Sumatriptan Arzneimittel (parenteral exkl. PEN)
Tofacitinib Arzneimittel
Pankreatin vom Schwein Arzneimittel (größer 25000 PhEur-E.)
Ustekinumab Arzneimittel
Vericiguat Arzneimittel
Zidovudin Arzneimittel (HKP)
Zolmitriptan Arzneimittel (nasal)
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
712 days remaining(LOT-0001)
Published